Companies
Discover all trending biotech companies
Discover all trending biotech companies
Company Research Platform
Annual Revenue
$ 2,066,100,000
Global Employees
2,467
R&D Investment
174100000
This segment focuses on developing and providing comprehensive solutions for the diagnosis and treatment of eye diseases. It encompasses a wide range of products, including systems and consumables for cataract, retinal, and refractive surgeries. Research and development efforts are directed towards enhancing surgical precision, improving patient outcomes, and expanding the applications of existing technologies. The segment serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. Future opportunities include expanding the use of AI in diagnostics and personalized treatment plans, as well as developing minimally invasive surgical techniques.
The Microsurgery segment offers advanced visualization solutions for invasive surgical treatments across various medical disciplines. These include solutions for ear, nose, and throat (ENT), plastic and reconstructive surgery, dental surgery, and spinal surgery. The segment's research and development activities are focused on improving surgical precision, enhancing visualization capabilities, and developing innovative surgical tools. Technologies employed include advanced optics, robotics, and digital imaging. The segment serves physicians in various fields and hospitals, aiming to improve surgical outcomes and patient recovery times. Future growth potential lies in the development of robotic-assisted surgical platforms and integration of AI for real-time surgical guidance.